New Jersey 2024-2025 Regular Session

New Jersey Senate Bill S3955

Introduced

12/12/24

Refer

12/12/24

Report Pass

3/3/25

Refer

3/17/25

Report Pass

3/17/25

Caption

Prohibits use of deceptive marketing practices by substance use disorder treatment providers.

Companion Bills

NJ A3974

Same As Prohibits use of deceptive marketing practices by substance use disorder treatment providers.

Previously Filed As

NJ A3974

Prohibits use of deceptive marketing practices by substance use disorder treatment providers.

NJ S3254

Prohibits substance use disorder treatment providers from using deceptive marketing practices.

NJ A4032

Prohibits substance use disorder treatment providers from using deceptive marketing practices.

NJ SB349

California Ethical Treatment for Persons with Substance Use Disorder Act.

NJ HB1045

Treatment for Substance Use Disorders

NJ A3978

Establishes "Substance Use Disorder and Addiction Treatment Best Practices Task Force."

NJ S3956

Establishes "Substance Use Disorder and Addiction Treatment Best Practices Task Force."

NJ SB913

Substance use disorder treatment: facilities.

NJ S3952

Revises law concerning patient referrals to substance use disorder treatment facilities, recovery residences, and clinical laboratories.

NJ AB77

Substance use disorder treatment services.

Similar Bills

LA HB1024

Provides with respect to drug free zones

CA SB1290

Substance abuse disorder treatment.

NJ A3974

Prohibits use of deceptive marketing practices by substance use disorder treatment providers.

CA AB136

Personal Income Tax Law: deductions: charitable contributions: business expenses.

NJ A2972

Requires DHS to establish sobriety standards and drug testing requirements for substance use disorder treatment centers and to conduct both announced and unscheduled inspections.

CA AB1098

Recovery residences.

CA SB1334

Substance use disorder treatment: licensing.

MN SF271

Substance abuse counselors license requirements modifications and treatment requirements modifications